Learn more

CL PHARMA

Overview
  • Total Patents
    128
About

CL PHARMA has a total of 128 patent applications. Its first patent ever was published in 1987. It filed its patents most often in United States, German Democratic Republic and EPO (European Patent Office). Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and biotechnology are ZHU ZHAONING, SYNTEX LAB and VALO EARLY DISCOVERY INC.

Patent filings per year

Chart showing CL PHARMAs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Binder Dieter 33
#2 Rovenszky Franz 30
#3 Schermanz Karl 21
#4 Saischek Gerald 21
#5 Ferber Hubert Peter 19
#6 Urmann Robert 12
#7 Ferber Hubert P 12
#8 Kores Dietmar 11
#9 Martetschlaeger Kurt 11
#10 Baumann Karl 11

Latest patents

Publication Filing date Title
FR2737121A1 New galenic formulations of fenofibrate and their applications
WO9005181A1 PURIFICATION OF Cu/Zn SUPEROXIDEDISMUTASE________________________
IE893460L Preparation of 3,5-dimethyl-4-methoxypyridines
WO9002134A1 New citydin-5'-diphosphate alkanols and glycerols, a process for preparing them and their use
NZ229783A Allylaminoethylazoles; fungicidal and antimycotic compositions, methods for preparation and combating fungi
IE892057L (n-allylaminoethyl) azoles
ATA278988A Method for producing 3-5-dimethyl-4methoxypyridine derivatives and new intermediate product therefor
WO8904370A1 Human monoclonal anti-hiv-i-antibodies
NZ226477A Substituted thieno (2,3-e)-1,2 thiazine derivatives and pharmaceutical compositions
ATA112388A Method for producing 5-chlorine-3chloresulfonyl-2-thiophenicarbonic acid esters
CN1023481C 2-Thiophenyloxyaetic acids, process for their preparation and pharmaceutical preparations containing them
EP0284893A2 Thienoimidazo[2,1-b]thiazole derivatives, process for their preparation and pharmaceutical preparations containing them
EP0284892A1 Thienyloxyacetic acid derivatives, a process for their preparation, and pharmaceutical compositions containing them
US4841065A Isoxazole derivatives with antiviral activities and pharmaceutical products containing these